Zenotech Laboratories Limited (BOM:532039)
India · Delayed Price · Currency is INR 44.35
+0.09 (0.20%)
At close: Sep 16, 2026
Zenotech Laboratories Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 2,701 | 2,093 | 3,169 | 3,608 | 2,872 | 3,073 | |
Market Cap Growth | -20.42% | -33.96% | -12.16% | 25.61% | -6.53% | 43.86% |
Enterprise Value | 2,397 | 1,775 | 2,949 | 3,454 | 2,788 | 3,161 |
Last Close Price | 44.26 | 34.29 | 51.92 | 59.11 | 47.06 | 50.35 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | 56.45 | 43.47 | 24.79 | 13.86 |
PS Ratio | 6.67 | 5.21 | 8.10 | 9.80 | 7.36 | 9.33 |
PB Ratio | 2.84 | 2.20 | 3.30 | 3.98 | 3.49 | 4.35 |
P/TBV Ratio | 2.84 | 2.20 | 3.30 | 3.98 | 3.49 | 4.35 |
P/FCF Ratio | 143.49 | 111.17 | 56.33 | 47.54 | 19.90 | 19.54 |
P/OCF Ratio | 26.47 | 20.51 | 33.20 | 30.51 | 13.90 | 17.39 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 5.92 | 4.42 | 7.54 | 9.39 | 7.15 | 9.60 |
EV/EBITDA Ratio | 31.95 | 17.99 | 20.60 | 19.96 | 13.05 | 17.65 |
EV/EBIT Ratio | - | 64.43 | 40.07 | 33.79 | 19.65 | 28.89 |
EV/FCF Ratio | 127.33 | 94.31 | 52.43 | 45.52 | 19.32 | 20.10 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | - | - | - | - | - | 0.09 |
Debt / EBITDA Ratio | - | - | - | - | - | 0.33 |
Debt / FCF Ratio | - | - | - | - | - | 0.38 |
Net Debt / Equity Ratio | -0.32 | -0.32 | -0.28 | -0.22 | -0.13 | 0.05 |
Net Debt / EBITDA Ratio | -4.05 | -3.08 | -1.86 | -1.14 | -0.52 | 0.20 |
Net Debt / FCF Ratio | - | -16.16 | -4.75 | -2.59 | -0.77 | 0.23 |
Asset Turnover | - | 0.36 | 0.36 | 0.36 | 0.40 | 0.37 |
Inventory Turnover | - | 43.38 | 9.10 | 6.99 | 37.00 | 27.60 |
Quick Ratio | - | 3.36 | 2.85 | 1.81 | 0.91 | 0.42 |
Current Ratio | - | 3.40 | 2.89 | 1.94 | 0.98 | 0.47 |
Return on Equity (ROE) | - | -1.12% | 6.01% | 9.60% | 15.15% | 37.26% |
Return on Assets (ROA) | - | 1.55% | 4.24% | 6.17% | 9.10% | 7.60% |
Return on Invested Capital (ROIC) | -0.59% | -1.05% | 5.51% | 10.73% | 15.60% | 15.54% |
Return on Capital Employed (ROCE) | - | 2.80% | 7.50% | 11.00% | 16.80% | 13.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -0.93% | -0.51% | 1.77% | 2.30% | 4.03% | 7.22% |
FCF Yield | 0.70% | 0.90% | 1.77% | 2.10% | 5.03% | 5.12% |